<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211116053072N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-11-14</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Comparing the effects of electroacupuncture versus acupuncture in radicular low back pain:A randomized controlled trial</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the effects of electroacupuncture versus acupuncture in radicular low back pain:A randomized controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-12-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>https://irct.ir/trial/94283</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: An independent statistician who is not involved in participant recruitment, intervention delivery, or outcome assessment will generate the allocation sequence using a computerized random number generator and permuted blocks of fixed size six. Each block will contain three assignments to the acupuncture group and three to the electroacupuncture group in random order, yielding a 1:1 allocation ratio. The statistician will retain the allocation list, and the person responsible for recruitment will have no access to it. After eligibility is confirmed, informed consent is obtained, and the participant is enrolled, the statistician will use the next assignment in the sequence and communicate that participant’s group directly to the treating clinician, Blinding description: The following individuals will be blinded to treatment allocation in this study:
Pre- and post-intervention assessments and patient exercise therapy will be conducted by a sports medicine resident who is a member of the research team and will remain blinded to patients’ treatment allocation.
Patients will be blinded to their assigned treatment group.
Data analysis will be performed by a statistical consultant who will remain blinded to patients’ treatment allocation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Radicular low backpain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this group, traditional Chinese acupuncture was administered by a licensed specialist using sterile, single-use needles. The selected acupoints included lumbar and gluteal points corresponding to the primary meridians (e.g., BL60, BL23, BL25, BL40, GB30, and GV3). Each session lasted 20 minutes, with treatment sessions conducted three times per week for four consecutive weeks (totaling 12 sessions). Additionally, patients were instructed to perform specific core and lumbar strengthening exercises according to a prescribed protocol and were required to record their compliance in a logbook.The prescribed exercises included:- Cat-Camel stretch- Supermans- Hamstring stretch- Bridge- Abdominal hollowing- Piriformis stretch. Intervention 2: Intervention group: Group 2: Electroacupuncture and Therapeutic ExerciseIn this group, the same acupoints selected in Group 1 are utilized; however, an electrical current with a mean frequency of 19 Hz and adjustable amplitude is applied via the needles. The stimulation intensity is titrated to the patient's maximum tolerable threshold. Similar to Group 1, sessions are conducted three times per week for four consecutive weeks (totaling 12 sessions). The exercise regimen is identical to that of Group 1, and compliance is recorded in a logbook.In both groups, patients are instructed to refrain from using non-steroidal anti-inflammatory drugs (NSAIDs), with the exception of acetaminophen, for the management of severe pain throughout the study period.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No further information is available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyedeh Fatemeh Hosseini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rasoul Akram Hospital, Maziar Mansouri Ave., Setarkhan St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1445613131</zip>
        <telephone>+98 21 6435 2446</telephone>
        <email>drsfh94@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Houman Angourani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rasoul Akram Hospital, Maziar Mansouri Ave., Setarkhan St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1445613131</zip>
        <telephone>+98 21 6435 2446</telephone>
        <email>angoorani.h@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 18 and 65 years
Availability of a lumbar spine MRI confirming lumbar discopathy
Definitive diagnosis of lumbar disc herniation confirmed by MRI, with associated radicular symptoms
Radiating low back pain into the lower extremities persisting for at least one month, with a minimum pain intensity of 4 on the Visual Analogue Scale (VAS)."
Body mass index (BMI) between 20 and 35 kg/m².
Ability to undergo the planned therapeutic interventions (absence of a cardiac pacemaker and no functional limitations attributable to underlying medical conditions)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of trauma or physical injury to the lumbar region
Evidence of disc sequestration on lumbar spine MRI
Presence of an indication for surgical disc repair based on clinical evaluation or imaging findings
Engagement in strenuous physical activity (occupational or non-occupational) during the study period
History of physiotherapy or any injection-based treatment (including corticosteroid injections) within the past three months
History of low back pain attributable to inflammatory, infectious, or neoplastic causes
Presence of red flags, including nocturnal awakening due to pain, night sweats, excessive weight loss within the past six months, or fever
Pregnancy or a history of spinal surgery
History of spinal disorders, including cauda equina syndrome, spondylolisthesis, or unstable spondylolysis
History of psychiatric disorders or current use of psychotropic medication</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.16</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Radiculopathy, lumbar region</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this group, traditional Chinese acupuncture was administered by a licensed specialist using sterile, single-use needles. The selected acupoints included lumbar and gluteal points corresponding to the primary meridians (e.g., BL60, BL23, BL25, BL40, GB30, and GV3). Each session lasted 20 minutes, with treatment sessions conducted three times per week for four consecutive weeks (totaling 12 sessions). Additionally, patients were instructed to perform specific core and lumbar strengthening exercises according to a prescribed protocol and were required to record their compliance in a logbook.The prescribed exercises included:- Cat-Camel stretch- Supermans- Hamstring stretch- Bridge- Abdominal hollowing- Piriformis stretch</i_keyword>
      <i_keyword>Intervention group: Group 2: Electroacupuncture and Therapeutic ExerciseIn this group, the same acupoints selected in Group 1 are utilized; however, an electrical current with a mean frequency of 19 Hz and adjustable amplitude is applied via the needles. The stimulation intensity is titrated to the patient's maximum tolerable threshold. Similar to Group 1, sessions are conducted three times per week for four consecutive weeks (totaling 12 sessions). The exercise regimen is identical to that of Group 1, and compliance is recorded in a logbook.In both groups, patients are instructed to refrain from using non-steroidal anti-inflammatory drugs (NSAIDs), with the exception of acetaminophen, for the management of severe pain throughout the study period.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity. Timepoint: Pain intensity will be assessed at baseline (prior to intervention), at the end of the fourth week (post-intervention), and at a three-month follow-up after the completion of either acupunctural or electroacupuncture therapy and therapeutic exercise. Method of measurement: Visual Analog Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Degree of disability. Timepoint: Disability severity will be assessed at baseline (prior to intervention), at the end of the fourth week (post-intervention), and at a three-month follow-up after the completion of either acupunctural or electroacupuncture therapy and therapeutic exercise. Method of measurement: Oswestry Disability Index.</sec_outcome>
      <sec_outcome>Functional capacity. Timepoint: functional capacity will be assessed at baseline (prior to intervention), at the end of the fourth week (post-intervention), and at a three-month follow-up after the completion of either acupunctural or electroacupuncture therapy and therapeutic exercise. Method of measurement: 6 Minutes Walk Test.</sec_outcome>
      <sec_outcome>Lumbar flexion range of motion. Timepoint: Lumbar flexion range of motion (ROM) will be assessed at baseline (prior to intervention), at the end of the fourth week (post-intervention), and at a three-month follow-up after the completion of either acupunctural or electroacupuncture therapy and therapeutic exercise. Method of measurement: Modified Schober Test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-05-21</approval_date>
        <contact_name>Ethics Committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Vice Presidency for Research and Technology, Central Headquarters Building, Iran University of Medical Sciences, Hemmat Expressway, near Milad Tower, Tehran, Iran. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
